Tvardi Therapeutics, Inc 10-K for FY2023
Tvardi Therapeutics, Inc. (TVRD)
10-K
2024-03-06
For: 2023-12-31
View Original
Added on
April 09, 2026
About this 10-K
Tvardi Therapeutics, Inc filed this 10-K on March 6, 2024, covering the fiscal year ended December 31, 2023 (FY2023).
Headline figures
Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $20.97M
- down 49.9% from $41.87M a year earlier
- Net loss
- $118.51M
- compared with a net loss of $85.47M a year earlier
- Diluted EPS
- -$2.19
- compared with -$1.59 a year earlier